0001250853-23-000038.txt : 20230626 0001250853-23-000038.hdr.sgml : 20230626 20230626164317 ACCESSION NUMBER: 0001250853-23-000038 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100520 FILED AS OF DATE: 20230626 DATE AS OF CHANGE: 20230626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Palmer Richard NMN CENTRAL INDEX KEY: 0001413582 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12627 FILM NUMBER: 231042922 MAIL ADDRESS: STREET 1: 3806 NEWTON ST. CITY: TORRANC STATE: CA ZIP: 90505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Global Clean Energy Holdings, Inc. CENTRAL INDEX KEY: 0000748790 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 870407858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2790 SKYPARK DRIVE, SUITE 105 CITY: TORRANCE STATE: CA ZIP: 90505 BUSINESS PHONE: (310) 641-4234 MAIL ADDRESS: STREET 1: 2790 SKYPARK DRIVE, SUITE 105 CITY: TORRANCE STATE: CA ZIP: 90505 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL DISCOVERIES INC DATE OF NAME CHANGE: 19940303 FORMER COMPANY: FORMER CONFORMED NAME: WPI PHARMACEUTICAL INC DATE OF NAME CHANGE: 19930126 FORMER COMPANY: FORMER CONFORMED NAME: WESTPORT PHARMACEUTICAL INC DATE OF NAME CHANGE: 19850111 4 1 primary_doc.xml PRIMARY DOCUMENT X0407 4 2010-05-20 0 0000748790 Global Clean Energy Holdings, Inc. GCEH 0001413582 Palmer Richard NMN 2790 SKYPARK DRIVE SUITE 105 TORRANCE CA 90505 1 1 1 0 Chief Executive Officer 0 Common Stock 2010-05-20 4 G 0 1225000 0 D 58805241 D Common Stock 2011-05-04 4 G 0 20000 0 D 58785241 D Common Stock 2011-05-04 4 S 0 11000000 0.0414 D 47785241 D Common Stock 2020-12-31 4 G 0 990300 0 D 46794941 D Common Stock 2021-12-23 4 G 0 28912 0 D 4650585 D Stock Option (right to buy) 0.154 2018-10-16 4 A 0 11000000 0 A 2023-10-15 Common Stock 11000000 11000000 D 5% Convertible Note due October 15, 2020 0.154 2018-10-16 4 A 0 1000000 0 A 2018-10-16 2020-10-15 Common Stock 6493507 1000000 D 5% Convertible Note due October 15, 2020 0.154 2022-02-23 4 D 0 1000000 0 D 2018-10-16 2020-10-15 Common Stock 6493507 0 D 5% Convertible Note due February 23, 2024 0.154 2022-02-23 4 A 0 1000000 0 A 2022-02-23 Common Stock 7616305 1000000 D The Issuer effected a 1-for-10 reverse stock split of its Common Stock on March 26, 2021 (the Reverse Split). The Stock Option originally covered 110,000,000 shares at an exercise price of $0.0154 but has been adjusted to reflect the Reverse Split. The Reporting Person will vest, and can exercise the Stock Option, with respect to 40,000,000 shares when the market capitalization of the Issuer first reaches $7 million; another 40,000,000 shares will vest when the market capitalization of the Issuer first reaches $15 million; and the remaining 30,000,000 shares will vest when the market capitalization of the Issuer first reaches $25 million. The Note originally provided for a conversion price of $0.0154 but has been adjusted to reflect the Reverse Split. On February 23, 2022, the Issuer and the Reporting Person agreed to amend the Note that was originally issued on October 16, 2018, in order to, among other things, extend the maturity date. The maturity date of the Note is the later of February 23, 2024 or the date that the Series C Preferred Shares of the Issuer have been redeemed in full pursuant to the Certificate of Designations of Series C Preferred Stock. The amended Note provides that the maximum number of shares into which the Note may be converted is 7,616,305 /s/ Richard Palmer 2023-06-26